Kennedy Capital Management’s CytRx Corp CYTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-81,357
Closed -$1.65M 788
2015
Q1
$1.65M Sell
81,357
-35,735
-31% -$665K 0.03% 607
2014
Q4
$1.93M Buy
117,092
+28,910
+33% +$451K 0.04% 571
2014
Q3
$1.34M Sell
88,182
-4,131
-4% -$81.6K 0.03% 623
2014
Q2
$2.31M Buy
92,313
+7,873
+9% +$179K 0.04% 528
2014
Q1
$1.77M Buy
+84,440
New +$3M 0.03% 563

Other funds holding CYTR

Kennedy Capital Management's CYTR Position: Q2 2015 in Review

Kennedy Capital Management sold out of CytRx Corp (CYTR) in Q2 2015, closing a stake of 81,357 shares — an estimated $1.65M sold.

Kennedy Capital Management first reported a position in CYTR in Q1 2014 and held it in 5 quarters. The position peaked at $2.31M in Q2 2014. 68 funds tracked by Wall St. Rank hold CYTR as of Q2 2015.

  • Kennedy Capital Management reported no remaining CytRx Corp position as of Q2 2015 after selling out during the quarter.
  • Kennedy Capital Management sold 81,357 CytRx Corp shares in Q2 2015, an estimated $1.65M.
  • Kennedy Capital Management first reported a position in CytRx Corp in Q1 2014 and held it in 5 quarters.
  • Kennedy Capital Management's CytRx Corp position peaked at $2.31M in Q2 2014.
  • 68 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2015.

Based on Kennedy Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.